BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 16/03/2021

FDA Reopens Comment Period for Draft Guidance on Proprietary Names for Human Nonprescription Drugs

The FDA is extending the comment period for its draft guidance on developing proprietary names for human nonprescription drugs, allowing more time for industry stakeholders to submit feedback

Source: Federal Register — Food and Drug AdministrationOpen original release →